Fox K K, Knapp J S
Epidemiology and Surveillance Branch, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Curr Opin Urol. 1999 Jan;9(1):65-70. doi: 10.1097/00042307-199901000-00011.
Despite a declining incidence of gonorrhea in much of the industrialized world, antimicrobial resistance continues to present a challenge to the treatment of gonococcal infections. Although no clinically significant resistance to the broad-spectrum cephalosporins has been identified, fluoroquinolone-resistant gonococcal strains are now prevalent in Australia and much of the Far East. Ongoing surveillance for antimicrobial resistance is crucial to obtain the information needed to choose effective empiric therapies for gonorrhea.
尽管在许多工业化国家淋病发病率呈下降趋势，但抗菌药物耐药性仍然是淋病治疗面临的一项挑战。虽然尚未发现对广谱头孢菌素具有临床显著耐药性的情况，但耐氟喹诺酮淋病菌株目前在澳大利亚和远东大部分地区很普遍。持续监测抗菌药物耐药性对于获取选择有效的淋病经验性治疗所需信息至关重要。
